|
|
| CAS No. | 875337-44-3 |
| Chemical Name: | MGCD-265 |
| Synonyms: | MGCD-265;MGCD-265 (Synonyms MGCD265);N-(3-fluoro-4-(2-(1-Methyl-1H-iMidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbaMothioyl)-2-phen;N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide;N-[[[3-fluoro-4-[[2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy]phenyl]amino]thioxomethyl]-benzeneacetamide;N-(3-Fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide MGCD-265 |
| CBNumber: | CB72515097 |
| Molecular Formula: | C26H20FN5O2S2 |
| Formula Weight: | 517.5977032 |
| MOL File: | 875337-44-3.mol |
|
|
|
|
MGCD-265 Chemical Properties,Usage,Production |
Usage
MGCD-265 is a multi-targeted kinase inhibitor, which targets the c-MET, VEGFR1, VEGFR2, VEGFR3, Tie-2 and Ron receptor tyrosine kinases. |
|
Usage
MGCD-265 is a novel dual c-Met/ VEGFR2 receptor tyrosine kinase inhibitor possessing favorable pharmacokinetic profiles and showed high efficacy in vivo in several human tumor xenograft models in mice
. |
|
|
| MGCD-265 Preparation Products And Raw materials |
Raw materials
|
Preparation Products
|
| MGCD-265 Suppliers Global( 33)Suppliers |
|
|
|
|
|